双鹭药业：参股公司轩竹生物拟在香港联交所主板挂牌上市

Core Viewpoint - The company Shuanglu Pharmaceutical (002038) announced that its associate company, XuanZhu Biotechnology Co., Ltd., is expected to officially list on the main board of the Hong Kong Stock Exchange on October 15, 2025 [1] Summary by Relevant Categories - Company Information - Shuanglu Pharmaceutical will hold a total of 1.7808 million shares in XuanZhu Biotechnology after the completion of the offering, which is expected to account for 0.34% of the total shares post-issuance [1]